Updating CMV protocols in lung transplant patients: a single-center case study modeling use of generative AI for antimicrobial stewardship protocol development and economic impact analysis
Infection Control & Hospital Epidemiology · 2026
DOI: 10.1017/ice.2026.10480 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Infection Control & Hospital Epidemiology, 2026. Verfasst von Kyle T Enriquez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, USA. Hauptthemen laut MEDLINE: Lung Transplantation, Cytomegalovirus Infections, Antimicrobial Stewardship, Antiviral Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Antimicrobial Stewardship Programs (ASPs) need healthcare economic analyses to support and inform ASP strategies. This work aimed to determine whether widely available artificial intelligence (AI) platforms like Microsoft Copilot TM could facilitate healthcare economics analyses for ASP programs without dedicated healthcare economic supports.
Design
AI (Microsoft Copilot TM ) was prompted to develop a cytomegalovirus prophylaxis protocol for lung transplant recipients using only PubMed-indexed articles. Copilot TM was then prompted to produce probabilistic samples of simulated patients from aggregate statistics of a 165-patient cohort from Vanderbilt University Medical Center and to analyze cost-effectiveness across four distinct cytomegalovirus prophylaxis protocols, including its own.
Setting
Tertiary care academic medical center, including outpatient and inpatient environments. Patients or participants: Simulated patient data was developed via random, single-blind, probabilistic selection from pre-defined aggregate cohort statistics.
Results
The AI-generated prophylaxis protocol was evidence-based without hallucination, but this conservative protocol relied on outdated evidence and was associated with significant increases in expected per-patient cost (mean +$4740, P < .01) compared to recent guideline-based and institutional protocols. AI independently identified and executed sensitivity analyses, which revealed that in this simplified model, letermovir use had a large impact on expected per-patient cost.
Conclusions
The AI-proposed protocol was less cost-effective, but data suggest that careful prompting can provide appropriate PubMed-indexed literature to support ASP protocol development. Additionally, CoPilot TM provided a thorough cost-effectiveness analysis comparing all potential and existing protocols. With appropriate oversight, AI and Microsoft Copilot TM can conduct healthcare economic analyses suitable for ASP strategic planning and implementation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical Scientist Training Program, Vanderbilt University School of Medicine, Nashville, USA.
- Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, USA.
ORCID-Profile: Kyle T Enriquez, Augusto Dulanto Chiang, Casey Smiley, Milner Staub
Zitieren
APA
Enriquez, K. T., Dulanto Chiang, A., Smiley, C., & Staub, M. (2026). Updating CMV protocols in lung transplant patients: a single-center case study modeling use of generative AI for antimicrobial stewardship protocol development and economic impact analysis. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2026.10480
Vancouver
Enriquez KT, Dulanto Chiang A, Smiley C, Staub M. Updating CMV protocols in lung transplant patients: a single-center case study modeling use of generative AI for antimicrobial stewardship protocol development and economic impact analysis. Infection Control & Hospital Epidemiology. 2026. doi:10.1017/ice.2026.10480
BibTeX
@article{Enriquez2026,
author = {Enriquez, Kyle T and Dulanto Chiang, Augusto and Smiley, Casey and Staub, Milner},
title = {Updating CMV protocols in lung transplant patients: a single-center case study modeling use of generative AI for antimicrobial stewardship protocol development and economic impact analysis},
journal = {Infection Control & Hospital Epidemiology},
year = {2026},
doi = {10.1017/ice.2026.10480}
}
EUVIMED